blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2404611

EP2404611 - Peptide for the prophylactic or therapeutic treatment of skin tumours in initial stages [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.11.2014
Database last updated on 04.11.2024
Most recent event   Tooltip07.11.2014Application deemed to be withdrawnpublished on 10.12.2014  [2014/50]
Applicant(s)For all designated states
Digna Biotech, S.L.
Avenida Pío XII, 22. Oficina 2
31008 Pamplona Navarra / ES
[2012/41]
Former [2012/02]For all designated states
ISDIN S.A.
Diagonal 520
08006 Barcelona / ES
Inventor(s)01 / INSA BORONAT, Raul
C/ Rosa Sensat 27 B 1a
E-08005 Barcelona / ES
02 / QUINTANILLA AVILA, Miguel
Instituto de Investigaciones Biomédicas Alberto
Sols CSIC-UAM
c/ Arturo Dupier 4
E-28029 Madrid / ES
03 / DOTOR DE LAS HERRERÍAS, Javier
Digna Biotech S.L.
Edificio Azysa
c/ Etxesakan 28
E- 31180 Cizur Mayor / ES
 [2012/02]
Representative(s)ZBM Patents - Zea, Barlocci & Markvardsen
Rambla Catalunya, 123
08008 Barcelona / ES
[N/P]
Former [2012/02]ZBM Patents
Zea, Barlocci & Markvardsen Plaza Catalunya, 1
08002 Barcelona / ES
Application number, filing date10748370.304.03.2010
WO2010ES70121
Priority number, dateES2009000069406.03.2009         Original published format: ES 200900694
[2012/02]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010100310
Date:10.09.2010
Language:ES
[2010/36]
Type: A1 Application with search report 
No.:EP2404611
Date:11.01.2012
Language:EN
[2012/02]
Search report(s)International search report - published on:ES10.09.2010
(Supplementary) European search report - dispatched on:EP18.10.2012
ClassificationIPC:A61P17/00, A61K38/17
[2012/47]
CPC:
A61K38/179 (EP,US); A61K38/10 (ES); A61P17/00 (EP);
A61P35/00 (EP); A61P35/04 (EP)
Former IPC [2012/02]A61K38/10, A61P17/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/02]
Extension statesAL06.10.2011
BA06.10.2011
ME06.10.2011
RS06.10.2011
TitleGerman:PEPTID FÜR DIE PROPHYLAKTISCHE ODER THERAPEUTISCHE BEHANDLUNG VON HAUTTUMOREN IM FRÜHSTADIUM[2012/02]
English:Peptide for the prophylactic or therapeutic treatment of skin tumours in initial stages[2012/02]
French:Peptide pour le traitement prophylactique ou thérapeutique de tumeurs de la peau, dans les stades initiaux[2012/02]
Entry into regional phase06.10.2011Translation filed 
06.10.2011National basic fee paid 
06.10.2011Search fee paid 
06.10.2011Designation fee(s) paid 
06.10.2011Examination fee paid 
Examination procedure06.10.2011Amendment by applicant (claims and/or description)
06.10.2011Examination requested  [2012/02]
20.01.2014Despatch of a communication from the examining division (Time limit: M05)
01.07.2014Application deemed to be withdrawn, date of legal effect  [2014/50]
25.07.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/50]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.01.2014
Fees paidRenewal fee
26.03.2012Renewal fee patent year 03
02.04.2013Renewal fee patent year 04
27.03.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2005084712  (ANTISENSE PHARMA GMBH [DE], et al);
 [X]EP1974740  (PROYECTO BIOMEDICINA CIMA SL [ES]);
 [XP]WO2009150284  (PROYECTO BIOMEDICINA CIMA SL [ES], et al);
by applicantWO0031135
 WO2007048857
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.